Process for preparing macrocyclic HCV protease inhibitors

Details Process for preparing macrocyclic HCV protease inhibitors Process for preparing macrocyclic HCV protease inhibitors

2008-05-20

2008-05-20

Kifle, Bruck (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C546S153000

Reexamination Certificate

active

07375218

ABSTRACT:
Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection:

REFERENCES:
patent: 2003/0181363 (2003-09-01), Llinas-Brunet et al.
patent: 2004/0248779 (2004-12-01), Dersch et al.
patent: 2005/0049187 (2005-03-01), Brandenburg et al.
patent: 2005/0080005 (2005-04-01), Llinas-Brunet et al.
patent: 2005/0209135 (2005-09-01), Busacca et al.
patent: WO 00/59929 (2000-10-01), None
patent: WO 03/064455 (2003-08-01), None
patent: WO 2004/089974 (2004-10-01), None
patent: WO 2005/028501 (2005-03-01), None
Mauro Napoletano, et al, The Synthesis and Biological Evaluation of a Novel Series of Phthalazine PDE4 Inhibitors I, Bioorganic & Medicinal Chemistry Letters 10 (2000) 2235-2238.
Frederick J. Brown, et al, Hydroxyacetophenone-Derived Antagonists of the Peptidoleukotrienes, J. Med. Chem. 1989, 32, 807-826.

Affiliated with

Also associated with

Rating

Process for preparing macrocyclic HCV protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing macrocyclic HCV protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing macrocyclic HCV protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2799367